page banner

News and Events

Exciting News: HaploX MRD Research Selected for Poster Presentation at ESMO Congress 2025!

2025-08-15

European Society for Medical Oncology (ESMO) was founded in Europe in 1975. Representing over 35,000 oncology professionals from 172 countries and regions worldwide, it is a globally renowned oncology academic organization. ESMO is dedicated to breaking down communication barriers related to cancer treatment between countries and specialties, fostering the advancement of oncology worldwide.

ASCO 2025

The ESMO Congress 2025 will be held in a hybrid format (both online and in-person) in Berlin, Germany, from 17 to 21 October 2025 (Central European Time). This conference aims to disseminate cutting-edge research advances in the field of oncology and provide high-level medical education and valuable academic exchange opportunities for global oncology scholars, oncologists, and other related healthcare professionals.

Research results from the collaboration between HaploX and Zhujiang Hospital of Southern Medical University have been successfully selected for Poster Presentation at this ESMO Congress!

ASCO 2025

HaploX consistently empowers precision oncology through innovative gene detection technology and reliable data analysis. This presentation of our research at ESMO is not only the fruit of our dedicated research team's hard work but also strong testament to the growing innovative strength of Chinese enterprises in the global field of precision cancer diagnosis and treatment!

Let us eagerly look forward to : At the upcoming ESMO Congress 2025, HaploX engaging in in-depth exchanges and collaboration with experts and scholars. Together, we will advance the progress of precision oncology technologies, ultimately benefiting patients worldwide!

contact us

Address

Units 610, 6/F, Building 16W, Phase 3, HongKong Science Park, New Territories, HongKong

Phone

+852 69410851

Email

customer_service@haplox.net

© 2025 HaploX Ltd. All Rights Reserved.